Clinical Trials Logo

Clinical Trial Summary

In this project, we will A) track the functioning of a collection of potential neurobiological targets for depression over time, B) examine how fluctuations in the functioning of those targets relates to real-world functioning, and C) in a subset of the sample, determine how the functioning in those targets is altered by a single dose of ketamine.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05991232
Study type Interventional
Source Ohio State University
Contact Jay Fournier, PhD
Phone 614-293-9889
Email jay.fournier@osumc.edu
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date May 2024
Completion date December 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05114824 - Acceptability and Feasibility of an 8-week Online Mindfulness-Based Cognitive Therapy Program Among Undergraduate Students N/A
Not yet recruiting NCT05958940 - BioClock: Bright Light Therapy for Depressive Disorders N/A
Completed NCT03556735 - Pulsed Electro Magnetic Fields (PEMF) in Depression N/A
Completed NCT04916548 - Repeated Neurocognitive Measurements in Depressed Patients Phase 1/Phase 2
Recruiting NCT05767073 - LIVES: Personalized Lifestyle Intervention for Patients With Depression N/A
Completed NCT06094907 - Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression Phase 2
Completed NCT04121091 - Pramipexole to Target "Anhedonic Depression" Phase 2
Recruiting NCT06092411 - Effects of CBT and BLT in Youth With Unipolar Depression and Evening Chronotype N/A
Enrolling by invitation NCT03847688 - Machine Learning to Predict Clinical Response to TMS
Completed NCT02945735 - Gaze Contingent Feedback in Major Depressive Disorder (MDD) N/A
Recruiting NCT06139159 - CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos N/A
Recruiting NCT05011864 - Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression N/A
Terminated NCT03537547 - Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder Phase 4
Completed NCT03515733 - PF-04995274 and Emotional Processing in Treatment Resistant Depression Phase 1
Completed NCT03516604 - PF-04995274 and Emotional Processing in Un-medicated Depression Phase 1
Completed NCT03538275 - Chronobiology and Depression: Circadian Analytics as a Biomarker for Depressive Subtypes
Active, not recruiting NCT03096886 - Novel Neural Circuit Biomarkers of Major Depression Response to CCBT N/A
Not yet recruiting NCT06462196 - Natural History of Depression, Bipolar Disorder and Suicide Risk
Completed NCT01874951 - Low-Dose Naltrexone for Depression Relapse and Recurrence Phase 2
Completed NCT03906175 - Whole-body Hyperthermia for Mild to Moderate Depressive Disorder N/A